Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Burnier

Showing results (1-10 of 284) with videos related to

Pageof 29
Sort By:
Current Hypertension Reports|June 13, 2015
Antihypertensive Combination Treatment: State of the ArtM Burnier
The Journal of International Medical Research|February 12, 2010
Telmisartan: a different angiotensin II receptor blocker protecting a different population?M Burnier
EDTNA/ERCA Journal (English Ed.)|December 21, 2005
Compliance in hypertensionM Burnier
Pharmacological Research|September 6, 2017
Drug adherence in hypertensionM Burnier
Circulation|February 15, 2001
Angiotensin II type 1 receptor blockersM Burnier
Experimental Nephrology|November 10, 1998
Sodium balance and hypertension: rare genetic disorders expose pathogenic mechanismsM Burnier
Praxis|February 11, 1997
[Endothelial factors and cardiac insufficiency]M Burnier
Praxis|July 30, 1997
[Innovations in ambulatory nephrology]M Burnier
Blood Pressure Monitoring|July 25, 2000
Long-term compliance with antihypertensive therapy: another facet of chronotherapeutics in hypertensionM Burnier
International Journal of Clinical Practice. Supplement|June 28, 2005
Selective Ang II (AT1) receptor blockade: a rational approach to end-organ protection in hypertensionM Burnier
Pageof 29

Showing results (1-10 of 284) with videos related to

Sort By:
Pageof 29
Current Hypertension Reports|June 13, 2015
Antihypertensive Combination Treatment: State of the ArtM Burnier
The Journal of International Medical Research|February 12, 2010
Telmisartan: a different angiotensin II receptor blocker protecting a different population?M Burnier
EDTNA/ERCA Journal (English Ed.)|December 21, 2005
Compliance in hypertensionM Burnier
Pharmacological Research|September 6, 2017
Drug adherence in hypertensionM Burnier
Circulation|February 15, 2001
Angiotensin II type 1 receptor blockersM Burnier
Experimental Nephrology|November 10, 1998
Sodium balance and hypertension: rare genetic disorders expose pathogenic mechanismsM Burnier
Praxis|February 11, 1997
[Endothelial factors and cardiac insufficiency]M Burnier
Praxis|July 30, 1997
[Innovations in ambulatory nephrology]M Burnier
Blood Pressure Monitoring|July 25, 2000
Long-term compliance with antihypertensive therapy: another facet of chronotherapeutics in hypertensionM Burnier
International Journal of Clinical Practice. Supplement|June 28, 2005
Selective Ang II (AT1) receptor blockade: a rational approach to end-organ protection in hypertensionM Burnier
Pageof 29